Long 7-isoprenoid side chain → much longer plasma t½ (~68 h) than MK-4 (~1 h). Same Gla-protein carboxylation as MK-4 but steadier exposure with once-daily dosing. Produced by gut bacteria and by Bacillus subtilis natto fermentation.
Half-Life & Elimination Curve (PO: 68h)
Plasma (PO)t½ Decay (68h)
0×t½0h100%(2.34 µg/L)
1×t½68h50%(1.17 µg/L)
2×t½5.7d25%(0.584 µg/L)
3×t½8.5d12.5%(0.292 µg/L)
4×t½11.3d6.3%(0.146 µg/L)
5×t½14.2d3.1%(0.073 µg/L)
Elimination t½68h (PO)
Rate Constant (ke)0.0102 h⁻¹
Time to Peak (Tmax)7.95h
Est. Peak (Cmax)2.34 µg/L
Clearance (CL)0.214 L/h
97% Washout (5×t½)14.2d
Dosing Guidelines
Oral (PO): Typical 133 mcg (Range: 100–200 mcg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 40% · Volume of Distribution (Vd): 21 L · Absorption (ka): 0.5 h⁻¹ (t½ka ≈ 1.39h) [PMID 17158229]